News
Pharmacy chain BENU is warning that a steep price increase for the blood thinner Eliquis is threatening patient access to ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit ...
Pharmaceutical companies have been in talks with the U.S. government to figure out how to bring drug prices down after President Trump signed in May an executive order that ties U.S. prices to the ...
5d
Zacks Investment Research on MSNBristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...
Bristol-Myers Squibb Company (NYSE:BMY) is one of the largest and most well-known American pharmaceutical companies.
The health landscape sees pivots as companies adjust strategies: Bristol Myers and Pfizer offer discounts on Eliquis, Newcastle University's IVF technique prevents genetic diseases, and Juul's ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc.
Bristol Myers' Reblozyl missed its primary goal in a Phase 3 anemia trial but showed positive secondary outcomes in ...
Pfizer and Bristol Myers Squibb have launched a direct-to-patient program offering their blood thinner Eliquis at a 40% discount for cash-paying patients. The list price for Eliquis (apixaban) is ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results